Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
Nanjing Maternity and Child Health Care Hospital, Nanjing (China)
6 More presentations in this session
Mr C. Rodrigues Rosa (Belo Horizonte, BR)
Doctor F. Gerardo (Amadora, PT)
Doctor L. Arcari (Rome, IT)
Associate Professor A. Nelson (Melbourne, AU)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
